amiloride, hydrochlorothiazide drug combination has been researched along with Apparent Mineralocorticoid Excess Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bedussi, F; Berruti, A; Dalla Volta, A; Ferrari, V; Fragni, M; Galli, D; Lazzari, B; Memo, M; Roca, E; Rossini, E; Sigala, S; Valcamonico, F; Vezzoli, S | 1 |
1 other study(ies) available for amiloride, hydrochlorothiazide drug combination and Apparent Mineralocorticoid Excess Syndrome
Article | Year |
---|---|
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity.
Topics: Amiloride; Androgens; Androstenes; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Combinations; Humans; Hydrochlorothiazide; Male; Mineralocorticoid Excess Syndrome, Apparent; Mineralocorticoids; Prostatic Neoplasms | 2017 |